Protease-Responsive Condensation of Engineered Proteins Drives Tumor-Targeted T-Cell Activation.
A masked extracellular phase-separation platform (Condenstim) is engineered enabling tumor microenvironment-specific condensate formation and establishes a generalizable strategy to control extracellular LLPS for both fundamental studies and therapeutic applications.